Results 111 to 120 of about 200,791 (194)

Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysis. [PDF]

Front Cardiovasc Med
Yang IN, Huang CY, Yang CT, Toh HS, Chang WT, Su LW, Lin YM, Wang MC, Wang HY, Liao CT.   +9 more
europepmc   +1 more source

Safety and efficacy of angiotensin receptor neprilysin inhibitor in improving cardiac function and blood pressure in dialysis patients. [PDF]

Front Med (Lausanne)
Zhou K, Zhang Q, Dong W, Li X, Sun Y, Zhang Y.   +5 more
europepmc   +1 more source

The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study. [PDF]

Ren Fail
Wang Y, Zhou C, Ma X, Shi Y, Zang X, Bai S, Hu Y, Lv Z, Hong H, Wang Y, Yan D, Yang X, Yu C, Jiang D, Zhuang S, Wang Y, Liu N.   +16 more
europepmc   +1 more source

Case Report: Angiotensin converting enzyme inhibitors vs. angiotensin receptor blockers in the management of chronic hypertension: a case of lisinopril-induced rhinorrhea. [PDF]

Front Allergy
Amudzi AA, Samale GR, Vela-Parada X.
europepmc   +1 more source

Study on the Effects of Angiotensin Receptor/Neprilysin Inhibitors on Renal Haemodynamics in Healthy Dogs. [PDF]

Int J Mol Sci
Ishizaka M, Yamamori Y, Hsu HH, Miyagawa Y, Takemura N, Ogawa-Yasumura M.   +5 more
europepmc   +1 more source

Exploring CYP2D6 polymorphisms and angiotensin receptor blocker response in the Bai hypertensive population. [PDF]

Pharmacogenet Genomics
Yang C, Zhang G, Shu C, Lv L, Liu Z, Tian Y, Tan Q, Wang Z, Hu S, Yang L, Sun N.   +10 more
europepmc   +1 more source

Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke. [PDF]

J Am Heart Assoc
Chang KC, Lin CH, Huang JA.
europepmc   +1 more source

Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction. [PDF]

Front Pharmacol
Lee CC, Te-Wei Kuan D, Chang KC, Chen ZW, Cheng JF, Lin TT, Lin LY, Wu CK.   +7 more
europepmc   +1 more source

Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages. [PDF]

Imeta
Li J, Wang SY, Yan KX, Wang P, Jiao J, Wang YD, Chen ML, Dong Y, Zhong JC.   +8 more
europepmc   +1 more source

Association between risk of Alzheimer's disease and related dementias and angiotensin receptor Ⅱ blockers treatment for individuals with hypertension in high-volume claims data. [PDF]

EBioMedicine
Lundin SK, Hu X, Feng J, Lundin KK, Li L, Chen Y, Schulz PE, Tao C.   +7 more
europepmc   +1 more source